1.0700
-0.1000
(-8.55%)
As of 11:59:13 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 75M | -- |
| Low Estimate | -- | -- | 75M | -- |
| High Estimate | -- | -- | 75M | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -4.59 | -4.14 | -1.23 |
| EPS Actual | -4.23 | -3.62 | -1.54 | -0.85 |
| Difference | -- | 0.97 | 2.6 | 0.38 |
| Surprise % | -- | 21.13% | 62.80% | 30.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PHIO | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2023 |
Related Tickers
HOTH Hoth Therapeutics, Inc.
0.8419
-9.74%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2800
+0.79%
SLRX Salarius Pharmaceuticals, Inc.
0.7765
-0.45%
REVB Revelation Biosciences, Inc.
2.6700
-4.39%
PALI Palisade Bio, Inc.
0.6499
-2.74%
ENVB Enveric Biosciences, Inc.
1.1600
-9.38%
PSTV Plus Therapeutics, Inc.
0.8020
+3.50%
SILO Silo Pharma, Inc.
1.0350
-7.62%
ENSC Ensysce Biosciences, Inc.
2.2000
-3.93%
ZVSA ZyVersa Therapeutics, Inc.
0.6277
-1.92%